About this trial
This study will contribute to the current literature that have compared joint injections with steroid versus ketorolac providing evidence for the use of ketorolac for SI joint pain. Currently steroid is the clinical standard for joint injections, however with repetitive use, steroid injections can damage the joint. Ketorolac is an alternative anti-inflammatory medication that does not cause the same joint damage and at a cheaper cost than steroid. The investigators hypothesize that ultrasound guided SI joint injections utilizing ketorolac provide the same pain relief as corticosteroid SI joint injections measured at 2, 6 and 12 weeks post injection. This would allow more frequent injections to control pain at a decreased cost to the healthcare system.
Eligibility criteria
Qualifiers
SI joint pain for at least 3 months
Age greater than 18
Must have at least 3 special tests positive for SI joint pain on physical exam
Disqualifiers
Previous back surgery
Radicular leg pain
Discogenic pain
Myofascial pain syndrome
Trial design
Treatments tested in this trial
- Methylprednisolone Injection
- Ketorolac Injection